Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LogicBio Therapeutics, Inc. | 6,466,783 | reported | 23 Oct 2018 | tx 7+6,466,783−10,078,289 |
| Adicet Bio, Inc. | 242,285 | reported | 10 Dec 2021 | tx 1+214,285 |
| Galecto, Inc. | 191,787 | reported | 02 Nov 2020 | tx 17+3,803,255−1,462,394 |
| SteadyMed Ltd. | 0 | reported | 30 Aug 2018 | tx 8+110,000−6,479,294 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Dec 2021 | GRANT_AWARD | Adicet Bio, Inc. | 214,285 | 14.00 USD | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 822,311 | — | |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 191,787 | — | |
| 02 Nov 2020 | PURCHASE | Galecto, Inc. | 523,833 | 15.00 USD | |
| 02 Nov 2020 | PURCHASE | Galecto, Inc. | 209,500 | 15.00 USD | first after silence |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 2,055,824 | — | |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 73,773 | 27.11 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 291,999 | — | deriv |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 148,395 | 27.11 USD | deriv |
| 25 Sept 2020 | GRANT_AWARD | Galecto, Inc. | 59,350 | 27.11 USD | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 73,773 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 59,350 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 148,395 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 31,147 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 77,866 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 109,013 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 272,533 | — | deriv |
| 02 Nov 2020 | CONVERSION | Galecto, Inc. | 116,800 | — | deriv |
| 23 Oct 2018 | PURCHASE | LogicBio Therapeutics, Inc. | 700,000 | 10.00 USD | |
| 23 Oct 2018 | PURCHASE | LogicBio Therapeutics, Inc. | 490,000 | 10.00 USD | |
| 23 Oct 2018 | CONVERSION | LogicBio Therapeutics, Inc. | 2,997,760 | — | |
| 23 Oct 2018 | CONVERSION | LogicBio Therapeutics, Inc. | 2,279,023 | — | |
| 23 Oct 2018 | CONVERSION | LogicBio Therapeutics, Inc. | 4,352,775 | 0.00 USD | deriv |
| 23 Oct 2018 | CONVERSION | LogicBio Therapeutics, Inc. | 3,046,943 | 0.00 USD | deriv |
| 23 Oct 2018 | CONVERSION | LogicBio Therapeutics, Inc. | 2,678,571 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 02 Nov 2020.